what data? AGILE not so sure that will be a good thing. its pretty much priced as a fail and most likley will be a fail. James was only ever an employee he has no value. The current CEO has no stock nor the two new directors it just a bottom feed fest now. The sad thing is the drugs work and those kids need it. Maybe if they spent more money producing the drug and less on new hires.
